<< Back To Home

Global alignment of immunization safety assessment in pregnancy - The GAIA project.

Friday, 23rd of December 2016 Print

 

Vaccine. 2016 Dec 1;34(49):5993-5997. doi: 10.1016/j.vaccine.2016.07.006. Epub 2016 Oct 14.

Global alignment of immunization safety assessment in pregnancy - The GAIA project

Bonhoeffer J1Kochhar S2Hirschfeld S3Heath PT4Jones CE4Bauwens J5Honrado Á6Heininger U7Muñoz FM8Eckert L9Steinhoff M10Black S10Padula M11Sturkenboom M12Buttery J13Pless R14Zuber P15GAIA project participants.

Author information

  • 1Brighton Collaboration Foundation, Basel, Switzerland; University of Basel Children´s Hospital, Basel, Switzerland. Electronic address: contact@brightoncollaboration.org.
  • 2Global Healthcare Consulting, Delhi, India.
  • 3Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, USA.
  • 4St George´s, University of London, London, UK.
  • 5Brighton Collaboration Foundation, Basel, Switzerland.
  • 6Synapse Research Management Partners, Barcelona, Spain.
  • 7University of Basel Children´s Hospital, Basel, Switzerland.
  • 8Baylor College of Medicine, Houston, USA.
  • 9University of Washington, Seattle, USA.
  • 10Cincinnati Children´s Hospital Medical Center, USA.
  • 11The Children´s Hospital of Philadelphia, PA, USA.
  • 12Erasmus University Medical Center, Rotterdam, The Netherlands.
  • 13Monash University, Melbourne, Australia.
  • 14Public Health Agency of Canada, Ottawa, Canada.
  • 15World Health Organization, Geneva, Switzerland.

Abstract below; full text is at http://www.sciencedirect.com/science/article/pii/S0264410X16305692

 

Immunization in pregnancy provides a promising contribution to globally reducing neonatal and under-five childhood mortality and morbidity. Thorough assessment of benefits and risks for the primarily healthy pregnant women and their unborn babies is required. The GAIA project was formed in response to the call of the World Health Organization for a globally concerted approach to actively monitor the safety of vaccines and immunization in pregnancy programs. GAIA aims to improve the quality of outcome data from clinical vaccine trials in pregnant women with a specific focus on the needs and requirements for safety monitoring in LMIC. In the first year of the project, a large and functional network of experts was created. The first outputs include a guidance document for clinical trials of immunization in pregnancy, a basic data collection guide, ten case definitions of key obstetric and neonatal health outcomes, an ontology of key terms and a map of pertinent disease codes. The GAIA Network is designed as an open and growing forum for professionals sharing the GAIA vision and aim. Based on the initial achievements, tools and services are developed to support investigators and strengthen immunization in pregnancy programs with specific focus on LMIC.

 

40957356